Announce Date | 02/12/2025 |
EPS Normalized Actual | $1.11 (Miss by $-0.04) |
EPS GAAP Actual | $1.11 (Miss by $-0.04) |
Revenue Actual | $2.857B |
Revenue Surprise | Beat by $2857M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 1 |
Dec 2025 | 2.86 | 9.17 | 2.67 | 2.95 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.92 | 0.92 | 2.857B | -5.82% | 2857M |
FQ3 2024 (Sep 2024) | 0.0538 | 0.0538 | 2.6288B | -1.89% | 2628.8M |
FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 2.71B | 1.61% | 2710M |
FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 2.4959B | -1.01% | 2495.9M |
FQ4 2023 (Dec 2023) | 1.21 | 1.21 | 3.0233B | 1.24% | 3023.3M |
FQ3 2023 (Sep 2023) | 0.64 | 0.64 | 2.6785B | 1.52% | 2678.5M |
FQ2 2023 (Jun 2023) | 0.69 | 0.69 | 2.6665B | -2.6% | 2666.5M |
FQ1 2023 (Mar 2023) | 0.33 | 0.33 | 2.521B | 100% | 2521M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.2229 | -- | 1.19948 | 1.25022 | 1 |
FQ3 2027 (Sep 2027) | 0.7768 | -- | 0.76192 | 0.79416 | 1 |
FQ2 2027 (Jun 2027) | 0.6214 | -- | 0.6095 | 0.63528 | 1 |
FQ1 2027 (Mar 2027) | 0.3817 | -- | 0.37439 | 0.39023 | 1 |
FQ4 2026 (Oct 2026) | 0.81789 | -- | 0.81215 | 0.82134 | 1 |
FQ3 2026 (Jul 2026) | 0.66765 | -- | 0.66296 | 0.67047 | 1 |
FQ2 2026 (Jun 2026) | 0.67878 | -- | 0.65304 | 0.74614 | 1 |
FQ1 2026 (Mar 2026) | 0.39408 | -- | 0.37913 | 0.43319 | 1 |
FQ4 2025 (Oct 2025) | 0.73776 | -24.7 | 0.73258 | 0.74088 | 2 |
FQ3 2025 (Jul 2025) | 0.62619 | 91.41 | 0.62179 | 0.62883 | 2 |
FQ2 2025 (Jun 2025) | 0.67172 | 13.65 | 0.64624 | 0.73838 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.8B | -- | 2.76B | 2.85B | 1 |
FQ3 2027 (Sep 2027) | 2.79B | -- | 2.75B | 2.84B | 1 |
FQ2 2027 (Jun 2027) | 2.78B | -- | 2.74B | 2.82B | 1 |
FQ1 2027 (Mar 2027) | 2.76B | -- | 2.72B | 2.81B | 1 |
FQ4 2026 (Oct 2026) | 2.51B | -- | 2.49B | 2.52B | 1 |
FQ3 2026 (Jul 2026) | 2.53B | -- | 2.51B | 2.54B | 1 |
FQ2 2026 (Jun 2026) | 2.54B | -- | 2.47B | 2.74B | 1 |
FQ1 2026 (Mar 2026) | 2.38B | -- | 2.31B | 2.56B | 1 |
FQ4 2025 (Oct 2025) | 2.4B | -19.04 | 2.39B | 2.41B | 0 |
FQ3 2025 (Jul 2025) | 2.42B | -8.7 | 2.41B | 2.43B | 0 |
FQ2 2025 (Jun 2025) | 2.44B | -11.29 | 2.36B | 2.62B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.92 | 0.92 | 100% | |
FQ3 2024 (Sep 2024) | 0.0538 | 0.0538 | 100% | |
FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 100% | |
FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 100% | |
FQ4 2023 (Dec 2023) | 1.21 | 1.21 | 100% | |
FQ3 2023 (Sep 2023) | 0.64 | 0.64 | 100% | |
FQ2 2023 (Jun 2023) | 0.69 | 0.69 | 100% | |
FQ1 2023 (Mar 2023) | 0.33 | 0.33 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.86B | $2857M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.63B | $2628.8M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.71B | $2710M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.5B | $2495.9M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.02B | $3023.3M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.68B | $2678.5M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.67B | $2666.5M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.52B | $2521M | 100% |